Bioray Biotech Co., Ltd (TPEX:7561)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
26.35
+0.10 (0.38%)
Sep 19, 2025, 9:49 AM CST

Bioray Biotech Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
7806359309011,290826
Upgrade
Market Cap Growth
-24.09%-31.64%3.17%-30.18%56.23%-
Upgrade
Enterprise Value
6765869118961,226756
Upgrade
Last Close Price
26.3521.3030.9029.7646.5129.94
Upgrade
PE Ratio
25.60634.18-1802.11--
Upgrade
PS Ratio
3.393.154.854.738.725.29
Upgrade
PB Ratio
1.771.512.142.003.552.22
Upgrade
P/TBV Ratio
1.771.512.152.013.582.26
Upgrade
P/FCF Ratio
24.9447.32----
Upgrade
P/OCF Ratio
23.2538.16-363.62146.17493.43
Upgrade
EV/Sales Ratio
2.942.904.754.708.294.84
Upgrade
EV/EBITDA Ratio
11.4748.59-56.76230.5080.79
Upgrade
EV/FCF Ratio
21.6343.61----
Upgrade
Debt / Equity Ratio
0.120.200.160.220.150.17
Upgrade
Debt / EBITDA Ratio
0.874.2613.554.684.994.11
Upgrade
Debt / FCF Ratio
1.646.39----
Upgrade
Asset Turnover
0.430.370.340.360.310.32
Upgrade
Inventory Turnover
2.172.402.102.241.722.10
Upgrade
Quick Ratio
5.305.333.522.772.202.33
Upgrade
Current Ratio
7.156.985.003.692.833.02
Upgrade
Return on Equity (ROE)
7.12%0.23%-2.61%0.12%-2.16%-0.38%
Upgrade
Return on Assets (ROA)
4.13%-0.50%-2.12%-0.04%-1.08%-0.03%
Upgrade
Return on Capital (ROIC)
4.44%-0.53%-2.29%-0.04%-1.19%-0.03%
Upgrade
Return on Capital Employed (ROCE)
7.40%-----
Upgrade
Earnings Yield
3.91%0.16%-1.24%0.06%-0.56%-0.01%
Upgrade
FCF Yield
4.01%2.11%-1.16%-6.34%-0.48%-5.97%
Upgrade
Dividend Yield
---0.67%--
Upgrade
Buyback Yield / Dilution
2.01%0.83%-7.37%-4.67%-0.14%0.09%
Upgrade
Total Shareholder Return
-0.83%-7.37%-3.99%-0.14%0.09%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.